BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 31133044)

  • 21. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
    Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
    PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis.
    Li W; Sun L; Lei J; Wu Z; Ma Q; Wang Z
    Oncol Rep; 2020 Jul; 44(1):382-392. PubMed ID: 32377752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
    Hwang HJ; Oh MS; Lee DW; Kuh HJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions.
    Feng H; Moriyama T; Ohuchida K; Sheng N; Iwamoto C; Shindo K; Shirahane K; Ikenaga N; Nagai S; Nakata K; Mizumoto K; Nakamura M
    J Exp Clin Cancer Res; 2021 Apr; 40(1):133. PubMed ID: 33858491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
    Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
    Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.
    Stalnecker CA; Grover KR; Edwards AC; Coleman MF; Yang R; DeLiberty JM; Papke B; Goodwin CM; Pierobon M; Petricoin EF; Gautam P; Wennerberg K; Cox AD; Der CJ; Hursting SD; Bryant KL
    Cancer Res; 2022 Feb; 82(4):586-598. PubMed ID: 34921013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression.
    Auciello FR; Bulusu V; Oon C; Tait-Mulder J; Berry M; Bhattacharyya S; Tumanov S; Allen-Petersen BL; Link J; Kendsersky ND; Vringer E; Schug M; Novo D; Hwang RF; Evans RM; Nixon C; Dorrell C; Morton JP; Norman JC; Sears RC; Kamphorst JJ; Sherman MH
    Cancer Discov; 2019 May; 9(5):617-627. PubMed ID: 30837243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
    Giannuzzo A; Saccomano M; Napp J; Ellegaard M; Alves F; Novak I
    Int J Cancer; 2016 Dec; 139(11):2540-52. PubMed ID: 27513892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer.
    Horioka K; Ohuchida K; Sada M; Zheng B; Moriyama T; Fujita H; Manabe T; Ohtsuka T; Shimamoto M; Miyazaki T; Mizumoto K; Oda Y; Nakamura M
    Int J Oncol; 2016 Apr; 48(4):1499-508. PubMed ID: 26846197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.
    Qian D; Lu Z; Xu Q; Wu P; Tian L; Zhao L; Cai B; Yin J; Wu Y; Staveley-O'Carroll KF; Jiang K; Miao Y; Li G
    Cancer Lett; 2017 Jul; 397():43-51. PubMed ID: 28336327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer.
    Yeo D; Phillips P; Baldwin GS; He H; Nikfarjam M
    Int J Cancer; 2017 May; 140(9):2101-2111. PubMed ID: 28109008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib suppresses fibroblast growth factor-2 expression in pancreatic ductal adenocarcinoma PANC-1 cells.
    Li J; Luo M; Wang Y; Shang B; Dong L
    Oncol Rep; 2016 Sep; 36(3):1345-52. PubMed ID: 27430377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine Profiling and Orthotopic Xenografing of Pancreatic Stellate Cells.
    Qian D; Tian L; Lu Z; Miao Y
    Methods Mol Biol; 2019; 1882():157-160. PubMed ID: 30378052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
    Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
    Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor.
    Eguchi D; Ikenaga N; Ohuchida K; Kozono S; Cui L; Fujiwara K; Fujino M; Ohtsuka T; Mizumoto K; Tanaka M
    J Surg Res; 2013 May; 181(2):225-33. PubMed ID: 22795353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8.
    Wang HC; Lin YL; Hsu CC; Chao YJ; Hou YC; Chiu TJ; Huang PH; Tang MJ; Chen LT; Shan YS
    Theranostics; 2019; 9(24):7168-7183. PubMed ID: 31695760
    [No Abstract]   [Full Text] [Related]  

  • 39. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.